sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

North America Radiopharmaceutical Theranostics Market Scope And Analysis

  • Report Code : TIPRE00029854
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 185
Buy Now

North America Radiopharmaceutical Theranostics Market Scope, Growth, Size and Share by 2028

Buy Now

North America Radiopharmaceutical Theranostics Market Report North America Radiopharmaceutical Theranostics Market Size and Share North America Radiopharmaceutical Theranostics Market Scope and Analysis

North America Radiopharmaceutical Theranostics Market Report Scope

Report Attribute Details
Market size in 2022 US$ 795.88 Million
Market Size by 2028 US$ 1,529.88 Million
Global CAGR (2022 - 2028) 11.5%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Product Type
  • Alpha Emitters
  • Beta Emitters
  • Positron Emission Tomography Tracers
By Radioisotope
  • Technetium-99
  • Gallium-68
  • Iodine-131
  • Iodine-123
  • Yttrium-90
  • Fluorine-18
  • Lutetium177
  • Copper 67
  • Copper 64
By Source
  • Nuclear Reactors and Cyclotrons
By Application
  • Targeted Therapeutic
  • Companion Diagnostic
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Market leaders and key company profiles
  • Bayer AG
  • GE HealthCare Technologies Inc
  • Curium
  • Lantheus Medical Imaging Inc
  • Telix Pharmaceuticals Ltd
  • Cardinal Health Inc
  • Advanced Accelerator Applications S A
  • Jubilant Radiopharma
  • Theragnostics